Introduction
To understand the mechanism of membrane fi ssion, we identifi ed and used a compound called Ilimaquinone (IQ), which vesiculates the Golgi apparatus via a trimeric G protein subunit βγ and a serine/threonine kinase called protein kinase D (PKD)-dependent process (Takizawa et al., 1993; Jamora et al., 1997 Jamora et al., , 1999 . Importantly, PKD is necessary for the biogenesis of TGN to cell surface transport carriers (Liljedahl et al., 2001 ; Bard and Malhotra, 2006) . The binding of PKD to TGN requires DAG (Baron and Malhotra, 2002) and is activated by Golgi-associated PKCη (Diaz Anel and Malhotra, 2005) . PKD activates the lipid kinase activity of PI4kinase IIIß to generate phosphoinositide 4-phosphate (PI4P) from PI, and regulates the binding of ceramide transfer protein CERT to PI4P. PI4P is required for TGNto-cell surface transport (Walch-Solimena and Novick, 1999; Audhya et al., 2000; Godi et al., 2004; Hausser et al., 2005 Hausser et al., , 2006 Fugmann et al., 2007) . The evidence for PKD's role in the formation of TGN to cell surface transport carriers is though use of a kinase-dead (KD) form and pharmacological inhibitors. The best evidence for PKD's direct involvement in membrane fi ssion requires that its depletion inhibits protein secretion. However, the problem is exacerbated by the fact that there are three isoforms of PKD in the mammalian cells (1, 2, and 3) (Rykx et al., 2003) , and all are involved in the formation of basolaterally directed transport carriers (Yeaman et al., 2004) . We believe we have now addressed this issue. Our fi ndings reveal that HeLa cells contain predominantly PKD2 and PKD3, and virtually no PKD1. PKD2 and PKD3 dimerize at the TGN and we suggest they activate different substrates. Importantly, depletion of PKD2 and PKD3 by siRNA inhibits TGN-to-cell surface transport. Under these conditions, cargo containing tubules and reticular membranes accumulate at the TGN. In contrast, overexpression of an activated PKD causes extensive vesiculation of TGN. These results demonstrate convincingly that PKD is a bona fi de component of membrane fi ssion used to regulate the number and size of TGN-to-cell surface transport carriers depending on the physiological (cargo) needs.
Results and discussion

Depletion of PKD2 and PKD3 inhibits TGNto-cell surface protein transport
RT-PCR-based analysis revealed that of the three PKD isoforms, only PKD2 and PKD3 were expressed in HeLa cells (Fig. 1 A) . These results were confi rmed by quantitative RT-PCR (qRT-PCR): PKD1-specifi c mRNA is virtually undetectable (10-and 12-fold lower) compared with PKD2 and PKD3, respectively (Fig. 1 B) . Specifi c siRNAs were designed to deplete PKD2 and PKD3 in HeLa cells. Western blotting with specifi c antibodies revealed a 70-75% reduction in the level of PKD2 and PKD3, respectively (Fig. 1, C and E) . By comparison, the level of β-actin was not affected by PKD-specifi c siRNAs (Fig. 1 D) .
To test the effect of PKD2 and PKD3 depletion on protein secretion, control cells and depleted HeLa cells were cotransfected with a plasmid expressing HRP containing the N-terminal signal sequence (SS) as described previously Dimeric PKD regulates membrane fi ssion to form transport carriers at the TGN P rotein kinase D (PKD) is recruited to the trans-Golgi network (TGN) through interaction with diacylglycerol (DAG) and is required for the biogenesis of TGN to cell surface transport carriers. We now provide defi nitive evidence that PKD has a function in membrane fi ssion. PKD depletion by siRNA inhibits traffi cking from the TGN, whereas expression of a constitutively active PKD converts TGN into small vesicles. These fi ndings demonstrate that PKD regulates membrane fi ssion and this activity is used to control the size of transport carriers, and to prevent uncontrolled vesiculation of TGN during protein transport.
together with a plasmid expressing placental alkaline phosphatase (PLAP), a GPI-anchored protein that contains an apical sorting signal (Lisanti et al., 1990; Lipardi et al., 2000) . The activities of HRP and PLAP released into the medium were measured by chemiluminescence . HRP secretion is inhibited by 82% in cells transfected by PKD2 siRNA and by 80% in cells transfected by PKD3 siRNA compared with control siRNA-transfected cells (Fig. 2 A) . None of the PKD siRNAs have any effect on PLAP secretion (Fig. 2 B) . These fi ndings strengthen our previous proposal that similarly to polarized cells that have distinct apical and basolateral targeting pathways, nonpolarized HeLa cells sort proteins into apicallike (PKD-independent) and basolateral-like (PKD-dependent) pathways (Yeaman et al., 2004) . Simultaneous depletion of PKD2 and PKD3 from HeLa cells did not have a synergistic effect in inhibiting HRP secretion (unpublished data). Because siRNA-based depletion is not complete, we suggest the residual PKD is suffi cient to support traffi cking from the TGN to the cell surface. To further ascertain the involvement of PKD2 and PKD3 in traffi cking, their involvement in the transport of vesicular stomatitis virus (VSV)-G protein was monitored. HeLa cells were fi rst cotransfected with either siRNA specifi c for PKD2, PKD3, or a control, and a fl uorescent-labeled siRNA to identify transfected cells. After 30 h, the cells were transfected with the tsO45 strain of VSV-G-GFP, which has a thermosensitive mutation causing it to unfold in the ER at the nonpermissive temperature of 39.5°C. Upon shifting cells to the permissive temperature of 32°C, tsO45VSV-G protein folds and is transported to the cell surface. The amount of VSV-G at the cell surface was quantifi ed by immunofl uorescence fl ow cytometry permitting analysis of more than 5,000 cells transfected with both siRNA and VSV-G-GFP. In control cells, VSV-G protein was found at the cell surface within 40 min of shift to 32°C. In PKD2-and PKD3-depleted cells (either individually or together), 50% less VSV-G was found at the cell surface (Fig. 2 C) . This is a signifi cant effect on the traffi cking of VSV-G to the cell surface considering that siRNA-based depletion of PKD is not complete, and the residual levels (25-30%) would support traffi cking, albeit at a slower rate.
Immunoelectron microscopy was used to monitor effects on the secretion of ss-HRP (cargo) in cells depleted of PKD2 and PKD3. Compared with control cells (Fig. 2 D) , PKD2 and PKD3 depletion resulted in accumulation of HRP containing highly fenestrated membranes, and large tubules in the trans region of the Golgi stacks (Fig. 2, E and F) . To quantitate the number of tubules in the TGN, 20 different Golgi stacks were visualized. In control cells there were 1 to 3 tubules per stack, whereas in PKD-depleted cells the number of tubules increased to 3 to 6 per stack. In sum, PKD depletion results in accumulation of HRP in the TGN and on average a 2.9-fold increase in the number of HRP-containing tubules per Golgi stack. We suggest that these tubules and fenestrated HRP-containing membranes would ordinarily be converted into small transport carriers by membrane fi ssion. However, depletion of PKD2 and PKD3 inhibits events leading to membrane fi ssion, thus accumulating cargo (in this instance HRP) in tubular elements.
PKD2 and PKD3 dimerize in vitro and in vivo and transphosphorylate
Why does depletion of either PKD2 or PKD3 affect Golgito-cell surface transport? Why is the other (nondepleted) isoform not functional under such conditions? Do these forms dimerize to activate downstream targets? To test this hypothesis, PKD2 and PKD3 were immunoprecipitated separately from HeLa cell lysates and Western blotted with anti-PKD3 and anti-PKD2, respectively. Western blotting pure recombinant PKD2 and 3 confi rmed the specifi city of the antibodies to PKD2 and PKD3 (Fig. 3 A) . The endogenous PKD2 and PKD3 were found to coprecipitate (Fig. 3 B) . Exogenously expressed GST-PKD2 and Flag-PKD3 also coprecipitate specifi cally (Fig. 3 C) . GST alone does not coprecipitate with Flag-PKD3, and Flag-HRP used as a negative control for Flag-tagged protein does not coprecipitate with GST-PKD2. It is interesting to note that Flag-PKD3 construct, when expressed, co-migrates with a fragment of a 34-kD apparent molecular weight. This product is specifi c for PKD3 because it only appears when Flag-PKD3 is expressed. Because the Flag tag is present at the N-terminal part of PKD3, this 34-kD fragment is a degradation product of PKD3 containing its cysteinerich domain. More interestingly, this degradation product (Flag-PKD3-Nterm) is also coimmunoprecipitated with GST-PKD2 ( Fig. 3 C, top right panel), suggesting that PKD3's cysteine-rich domain binds PKD2. Purifi ed, recombinant-tagged PKD2 and 3 incubated in vitro also coprecipitate, which reveals a direct interaction between PKD2 molecules, PKD3 molecules, and between PKD2 and PKD3 (Fig. 3 D) .
PKDs cycle between cytosol and the TGN. A kinasedead form binds to the TGN but fails to dissociate. Under such conditions, cargo-fi lled transport carriers form but fail to detach and grow into large tubules. PKD-KD is found both on the TGN and the tubules. Flag-PKD2-KD and GST-PKD3-WT were expressed in HeLa cells and the cells stained with anti-PKD2 and anti-GST antibody. Flag-PKD2-KD was localized to the TGN and the tubules and more interestingly, so was PKD3-WT. Similarly, in cells expressing GST-PKD3-KD, Flag-PKD2-WT was found on the TGN and the tubules (Fig. 3 E) . These fi ndings further strengthen our arguments that PKD2 and PKD3 form a dimer and reveal for the fi rst time the localization of the wild-type kinase on the TGN and the TGN-derived tubules, when the corresponding partner is a kinase-inactive form. The fact that these tubules do not detach indicates that both kinases have to be functionally active for membrane fi ssion. The binding of PKD to the Golgi membranes requires DAG (Baron and Malhotra, 2002) . However, PKD2 and PKD3 can interact in cells depleted of DAG (unpublished data). These fi ndings reveal that PKD2 and PKD3 dimerize in the cytoplasm before DAG-dependent recruitment to the TGN.
PKD1 in addition to autophosphorylation transphosphorylates other PKD1 molecules (Sanchez-Ruiloba et al., 2006) . We therefore tested whether PKD2 and PKD3 share this property. Flag-PKD2-KD, Flag-PKD3-KD, GST-PKD2-WT, and GST-PKD3-WT were expressed in 293T cells and immunoprecipitated by specifi c antibodies. The isolated (soluble) Flag-tagged PKD-KD (2 or 3) was incubated with or without the GST-tagged kinases WT (2 or 3) attached to the beads in a kinase buffer. The phosphorylation status of the kinase-dead proteins by wildtype kinases was determined by SDS-PAGE followed by autoradiography. Our results reveal that PKD2 transphosphorylates other PKD2 molecules and also PKD3, and similarly PKD3 transphosphorylates PKD2 and other PKD3 molecules (Fig. 3 F) .
A constitutively activated PKD converts TGN into small vesicles
If PKD depletion inhibits membrane fi ssion then its overactivation should cause extensive vesiculation. A constitutively activated PKD containing a CAAX domain was generated to test this hypothesis. Proteins containing CAAX domain at their C-terminal can be prenylated, which confers a greater hydrophobicity and membrane anchoring (Choy et al., 1999; Wright and Philips, 2006) . We reasoned that PKD-CAAX upon recruitment to the TGN through its C1domain ) will be inserted into the membrane via prenylation. This will retain activated PKD on TGN and hyperactivate the fi ssion process. A constitutively activated PKD (PKD-CA) was generated by replacing Ser744 and Ser 748 with glutamic acid to mimic the phosphorylated form, as described by Iglesias et al. (1998) . The kinase-dead form of PKD (PKD-KD) refers to PKD-K618N as described previously (Liljedahl et al., 2001) .
HeLa cells stably expressing a GFP-tagged form of mannosidase II (MannII-GFP) (Sutterlin et al., 2005) were transfected with PKD-WT, PKD-CAAX-WT, PKD-CAAX-CA, or PKD-CAAX-KD. 24 h after transfection the cells were visualized with anti-GST antibodies to detect transfected cells, and the organization of Golgi apparatus was visualized with MannII-GFP (early Golgi) or an antibody against TGN46 (late Golgi). In cells transfected with PKD-CAAX-CA, the Golgi (cis Golgi as well as TGN) was found fragmented, whereas in cells transfected with PKD-WT or PKD-CAAX-KD the Golgi was unaffected (Fig. 4 A) . In cells transfected with PKD-CAAX-WT, the Golgi was fragmented when expressed at high levels (Fig. 4 A,  line 2 ). The recruitment of PKD to TGN requires DAG, which is inhibited by treatment of cells with fumonisin B1 (FB1) that lowers the intracellular pool of DAG (Baron and Malhotra, 2002) . We found that depletion of DAG by FB1 inhibited the recruitment of PKD-KD and PKD-CAAX-KD to the Golgi membranes, and PKD-CAAX-CA mediated fragmentation of Golgi membranes (Fig. 4 B) . Thus, the CAAX motif does not provide any specifi city to PKD recruitment but simply anchors it to the TGN in a DAG-dependent manner.
To further ascertain the effects of constitutively activated PKD on the organization of Golgi membranes, the following constructs were coexpressed in HeLa cells; sialyltransferase (ST)-HRP and either PKD-WT, PKD-CAAX-WT, PKD-CAAX-CA, or PKD-CAAX-KD. The cells were fi xed and thin sections visualized by immunoelectron microscopy with anti-HRP antibody to visualize the resident enzyme ST of TGN (Fig. 5, A-D, left  panel) , or anti-TGN46 antibody, which is a cargo protein of the TGN-to-cell surface pathway (Fig. 5, E-H, right panel) . There was a defi nitive increase in the number of vesicles in the vicinity of Golgi stacks in cells expressing either PKD-CAAX-WT or PKD-CAAX-CA compared with PKD-CAAX-KD or PKD-WT (Fig. 5) . A quantitation of these images revealed a fi ve-to sevenfold increase in the number of vesicles containing TGN46 in cells expressing CAAX variants of PKD-WT or the constitutively activated form compared with PKD-WT or PKD-CAAX-KD (Table I) . Interestingly, there was a 20-and 25-fold increase in the number of ST-containing vesicles in cells expressing PKD-CAAX-WT and PKD-CAAX-CA, respectively, compared with PKD-WT or PKD-CAAX-KD. Thus, overexpression of the wildtype or constitutively activated form of PKD hyperactivates the fi ssion reaction, and causes extensive vesiculation of the TGN. We suggest that this reaction fi rst generates the normal cargo (TGN46 containing) transport vesicles, but the reaction continues and consumes domains containing Golgi resident enzymes that are ordinarily excluded from participating in TGN-to-cell surface transport reaction.
Conclusion
Our fi ndings clearly demonstrate the regulation of membrane fi ssion by PKD. But how does PKD regulate membrane fi ssion? As mentioned above, PKD is recruited by a DAG-dependent manner to the TGN and then activated by PKCη. We suggest that a PKD-dependent increase in local concentration of DAG separates transport carriers from the TGN by periplasmic fusion. This coat-and dynamin-independent (fi ssion) reaction is therefore fundamentally different from the process of COPI, COPII, and clathrin-coated vesicle biogenesis.
Materials and methods
RT-PCR
Total RNA was extracted from HeLa cells with Nucleospin RNAII (MacheryNagel) and reverse-transcribed with Titanium One-Step RT-PCR kit (Clontech Laboratories, Inc.) according to the manufacturer's instructions.
Quantitative RT-PCR
Reverse transcription was performed using 1 μg of purifi ed RNA, oligo dT, and SuperScript III reverse transcriptase (Invitrogen) in a 20-μl reaction.
Amplifi cation of each specifi c transcript was performed using RT templates for the Q-PCR to generate standard curves (ranging from 10 2 to 10 5 copies/μl). Real-time Q-PCR assays were performed with an Mx4000 Multiplex Quantitative QPCR System (Stratagene). Reactions were performed using 200-nM primers, 1 μl template/25 μl PCR reaction and the iTaq SYBR Green Supermix with ROX (Bio-Rad). A two-step PCR method (denaturation at 95°C for 30 s and annealing/extension at 60°C for 1 min) was used. Each assay included the analysis of the samples in duplicates. In addition, samples were run at least three times to check for interassay variability. Melting curve analyses were performed on all PCR reactions to check for specifi city of the amplifi cation. Real-time qRT-PCR analyses for β-actin were included as housekeeping genes to normalize the data.
Antibodies
Antibodies in this study included goat anti-GST (GE Healthcare), rabbit anti-GST (AbCam), sheep anti-human TGN46 (AbD Serotec), rabbit affi nitypurifi ed anti-PKD3 (Bethyl), rabbit affi nity-purifi ed anti-PKD2 (Bethyl) monoclonal anti-β-actin (Sigma-Aldrich), monoclonal anti-Flag (Sigma-Aldrich), AMCA donkey anti-rabbit (Jackson ImmunoResearch Laboratories), and Texas Cell culture and transfection 293-T cells, HeLa cells, and the cell line stably expressing a GFP-tagged form of mannosidase II (HeLa MannII-GFP) were grown in complete medium consisting of DME (Cellgro) containing 10% FCS and supplemented 
siRNA transfection
The day before transfection, HeLa cells were plated in order to ensure 50% confl uency on the day of transfection. Knockdown transfections were performed using 80 nM of purifi ed siRNA and Lipofectamine 2000 according to the manufacturer's protocol. For the VSV-G transport assay, specifi c targeting siRNA and siGlo Risc free-labeled nonspecifi c siRNA were mixed (ratio 4:1) with a fi nal concentration of 100 nM. siRNAs controls were from Dharmacon. The siRNA PKD3 and the siRNA PKD2 are Silencer-validated siRNAs from Ambion. ssHRP and PLAP secretion assay 30 h after transfection with siRNA, the cells were cotransfected with the SS-HRP-Flag and the pSEAP2-basic (Clontech Laboratories, Inc.) plasmid (carrying PLAP cDNA), using Lipofectamine 2000 (Invitrogen). 30 μl of extracellular media was harvested 48 h after the initial siRNA transfection. HRP activity was measured using enhanced chemiluminescence (ECL) as described previously . PLAP activity in the medium and in the cells was measured using the Phospha-Light System (Applied Biosystems) following the manufacturer's protocol. PLAP activity inside the cells was normalized by total protein concentration and used to normalize both HRP and PLAP secreted into the medium.
VSV-G transport assay
30 h after transfection with siRNA, the cells were transfected with ts045VSV-G-GFP construct and cultured at 40°C for 20 h. 100 μg/ml of cycloheximide was then added before a 2-h incubation at 20°C. After an incubation at 32°C for 40 min the cells were harvested with a cell dissociation buffer (Invitrogen) and fi xed with 4% paraformaldehyde. After blocking with PBS containing 1.5% serum and 0.1% sodium azide, the labeling of surface VSV-G-GFP was performed for a 30-min incubation at 4°C with the anti-VSV-G mAb 8G5F11, which is specifi c for the extracellular domain of VSV-G. After washings with the blocking buffer, the cells were incubated with the secondary (APC)-labeled anti-mouse IgG antibody (Jackson ImmunoResearch Laboratories) for 30 min at 4°C. After washing, the cells were analyzed on a FACScalibur fl ow cytometer (BD Biosciences). The amount of VSV-G present at the cell surface (APC positive) of cells transfected with both siRNA (cy3 positive) and VSV-G (GFP positive) after subtracting the background was normalized by the GFP intensity.
Immunoprecipitation
Transfected 293-T cells or HeLa cells were lysed in 50 mM Tris, pH 7.4, 150 mM NaCl, 1% Triton X-100, and protease inhibitors for 30 min at 4°C. After centrifugation at 13,000 rpm for 10 min, protein concentrations were measured in the lysates. 100 μg of extracts were incubated with the primary antibody (1:100) at 4°C and after 2 h, 30 μl of G-Sepharose beads (GE Healthcare) were added for 1 h. Immobilized proteins were released by boiling in Laemmli buffer and analyzed by SDS-PAGE. For Flagtagged proteins, 100 μg of cell lysates were incubated with anti-Flag M2 affi nity gel and eluted with 3×Flag peptide following the manufacturer's instructions (Sigma-Aldrich).
In vitro kinase assay
An equal amount of the indicated proteins purifi ed by immunoprecipitation from transfected 293-T cells was incubated for 10 min at 32°C in a buffer containing 50 mM Tris-HCl, 30 mM MgCl 2 , 0,3 mM ATP, 2 mM DTT, 0.2 μM PdBu, and 5 μCi ATPγP 32 . The reaction was stopped by addition of 6× SDS sample buffer and the samples were processed for SDS-PAGE and autoradiography.
In vitro binding assay
After immunoprecipitation with anti-GST antibody from transfected 293-T cell lysates, the purifi ed GST-tagged proteins bound to the beads were incubated with equal amount of purifi ed Flag-tagged proteins for 2 h at 4°C in 300 μl of PBS containing 0.1% Triton X-100 and 0.2%BSA. After extensive washes in the same buffer, the precipitates were eluted in 1× SDS sample buffer and processed for Western blotting.
PKD-CAAX constructs cloning
PKD-CAAX-CA, PKD-CAAX-WT, and PKD-CAAX-KD were cloned by PCR using GST-PKD-CA, GST-PKD-WT, and GST-PKD-KD, respectively, as templates as previously described ). The CAAX motif was appended by using a reverse primer containing the nucleotides coding for the CAAX motif MVLC: 5′-A A A T
C T A G A A A G C T T T C A C A T A A C G A G A C A G A G G A T G-C T G A C A C G C T C A C T G -3′.
Immunofl uorescence 24 h after transfection, HeLa cells expressing MannII-GFP grown on coverslips were fi xed with 4% formaldehyde in PBS for 10 min, blocked, and permeabilized with blocking buffer (0.05% Saponin and 0.2% BSA in PBS) for 20 min. The coverslips were incubated with primary antibodies diluted in blocking buffer for 2 h, washed, incubated with secondary antibodies diluted in blocking buffer for 1 h, washed, mounted using Fluor Save Reagent (Calbiochem), and visualized with a Nikon Eclipse TE2000-U microscope. Pictures were taken using MetaMorph software and deconvolved using AutoVisualize+AutoDeblur 9.3 software. The pictures were then opened in ImageJ v1.37 and Adobe Photoshop.
Electron microscopy
HeLa cells were depleted of both PKD2 and PKD3 as described above. The cells were transfected with SS-HRP and processed for immunoelectron microscopy, and HRP was visualized by staining with DAB and H 2 O 2 as described previously (Polishchuk et al., 2000) . HeLa cells were transfected with GST-tagged PKD WT, PKD-CAAX-CA, PKD-CAAX-WT, or PKD-CAAX-KD. Cells were fi xed in the mixture of 4% paraformaldehyde and 0.5% glutaraldehyde, washed, and labeled with anti-TGN46-specifi c antibody followed by an antibody conjugated with peroxidase as described previously (Polishchuk et al., 2000) . Then cells were incubated with polyclonal antibody against GST and subsequently with Nanogold-conjugated Fab fragment of anti-rabbit IgG. Nanogold particles were enhanced using the manufacturer's kit (Nanoprobes). ST-HRP-expressing cells were incubated directly with DAB and H 2 O 2 (Polishchuk et al., 2000) and then labeled with anti-GST antibody as described above. Cells were then embedded in Epon 812 and thin sections visualized in a Tecnai-12 electron microscope (FEI, Philips). Images were taken using an Ultra View CCD digital camera. Morphometric analysis of Golgi stacks was performed in 20 cells for each experimental condition using the ANALYSIS software.
Tubular profi les were defi ned as HRP-positive structures with length twice or more higher than thickness.
Statistics
The statistical signifi cance of the difference between means was determined using the t test. Differences were considered signifi cant at P < 0.01.
